Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Gastrointestinal Stromal Tumors (GIST) Industry Insight 2016 With Global API Manufacturers And 2023 Market Outlook

Tuesday, November 8, 2016 23:55
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The Report “Gastrointestinal Stromal Tumors (GIST) – Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Gastrointestinal Stromal Tumors (GIST) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Gastrointestinal Stromal Tumors (GIST) till 2023.

Key Companies covered in this report are Novartis AG, Pfizer Inc., Bayer AG, AB Science SA, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Veeda Clinical Research Limited, Merck & Co. Inc., Otsuka Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd. etc.

Get SAMPLE of Report Spread across 100 pages with 20 Figures Now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=669370

Scope

  • Report covers the disease overview including Etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
  • It also provides Gastrointestinal Stromal Tumors (GIST) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Gastrointestinal Stromal Tumors (GIST) market.
  • Identifying patient populations in the global “Gastrointestinal Stromal Tumors (GIST) market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the best opportunities for Gastrointestinal Stromal Tumors (GIST) therapeutics in each of the markets covered.
  • To understand the future market competition in the global Gastrointestinal Stromal Tumors (GIST) therapeutics market and Insightful review of the key market drivers and barriers.

 

List of Tables

Table 1: Drug Description

Table 2: Drug, Marketed Details United States (US)

Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015

Table 4: Drug, Patent Details for US

Table 5: Gastrointestinal Stromal Tumors (GIST) Drug Sales (USD Millions)-2023

Table 6: Global Epidemiology of Gastrointestinal Stromal Tumors (GIST) (2013-2023)

Table 7: Gastrointestinal Stromal Tumors (GIST) Global Market (USD Millions), (2013-2015)

Table 8: Gastrointestinal Stromal Tumors (GIST) Global Market (USD Millions), (2016-2023)

Table 9: Gastrointestinal Stromal Tumors (GIST) US Market (USD Millions), (2013-2015)

Table 10: Gastrointestinal Stromal Tumors (GIST) US Market (USD Millions), (2016-2023)

Table 11: Gastrointestinal Stromal Tumors (GIST) Germany Market (USD Millions), (2013-2015)

Table 12: Gastrointestinal Stromal Tumors (GIST) Germany Market (USD Millions), (2016-2023)

Table 13: Gastrointestinal Stromal Tumors (GIST) United Kingdom Market (USD Millions), (2013-2015)

Table 14: Gastrointestinal Stromal Tumors (GIST) United Kingdom Market (USD Millions), (2016-2023)

Table 15: Gastrointestinal Stromal Tumors (GIST) France Market (USD Millions), (2013-2015)

Table 16: Gastrointestinal Stromal Tumors (GIST) France Market (USD Millions), (2016-2023)

Table 17: Gastrointestinal Stromal Tumors (GIST) Italy Market (USD Millions), (2013-2015)

Table 18: Gastrointestinal Stromal Tumors (GIST) Italy Market (USD Millions), (2016-2023)

Table 19: Gastrointestinal Stromal Tumors (GIST) Spain Market (USD Millions), (2013-2015)

Table 20: Gastrointestinal Stromal Tumors (GIST) Spain Market (USD Millions), (2016-2023)

Table 21: Gastrointestinal Stromal Tumors (GIST) Japan Market (USD Millions), (2013-2015)

Table 22: Gastrointestinal Stromal Tumors (GIST) Japan Market (USD Millions), (2016-2023)

Table 23: Gastrointestinal Stromal Tumors (GIST) ROW Market (USD Millions), (2013-2015)

Table 24: Gastrointestinal Stromal Tumors (GIST) ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Gastrointestinal Stromal Tumors (GIST) Drug Sales (USD Millions)-2023

Figure 2: Global Epidemiology of Gastrointestinal Stromal Tumors (GIST) (2013-2023)

Figure 3: Gastrointestinal Stromal Tumors (GIST) Global Market (USD Millions), (2013-2015)

Figure 4: Gastrointestinal Stromal Tumors (GIST) Global Market (USD Millions), (2016-2023)

Figure 5: Gastrointestinal Stromal Tumors (GIST) US Market (USD Millions), (2013-2015)

Figure 6: Gastrointestinal Stromal Tumors (GIST) US Market (USD Millions), (2016-2023)

Figure 7: Gastrointestinal Stromal Tumors (GIST) Germany Market (USD Millions), (2013-2015)

Figure 8: Gastrointestinal Stromal Tumors (GIST) Germany Market (USD Millions), (2016-2023)

Figure 9: Gastrointestinal Stromal Tumors (GIST) United Kingdom Market (USD Millions), (2013-2015)

Figure 10: Gastrointestinal Stromal Tumors (GIST) United Kingdom Market (USD Millions), (2016-2023)

Figure 11: Gastrointestinal Stromal Tumors (GIST) France Market (USD Millions), (2013-2015)

Figure 12: Gastrointestinal Stromal Tumors (GIST) France Market (USD Millions), (2016-2023)

Figure 13: Gastrointestinal Stromal Tumors (GIST) Italy Market (USD Millions), (2013-2015)

Figure 14: Gastrointestinal Stromal Tumors (GIST) Italy Market (USD Millions), (2016-2023)

Figure 15: Gastrointestinal Stromal Tumors (GIST) Spain Market (USD Millions), (2013-2015)

Figure 16: Gastrointestinal Stromal Tumors (GIST) Spain Market (USD Millions), (2016-2023)

Figure 17: Gastrointestinal Stromal Tumors (GIST) Japan Market (USD Millions), (2013-2015)

Figure 18: Gastrointestinal Stromal Tumors (GIST) Japan Market (USD Millions), (2015-2023)

Figure 19: Gastrointestinal Stromal Tumors (GIST) ROW Market (USD Millions), (2013-2015)

Figure 20: Gastrointestinal Stromal Tumors (GIST) ROW Market (USD Millions), (2016-2023)

Order a Copy of This Report http://www.reportsnreports.com/purchase.aspx?name=669370

About Us:
ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 500,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements – first time and every time!

Contact Us:
sales@reportsandreports.com

+ 1 888 391 5441

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.